Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders — Stella

Home/Sickle Cell Disease/Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders

View on ClinicalTrials.gov

Recruiting

Back to Sickle Cell Disease trials

Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders

Trial locations(1 site)

United States

St. Jude Children's Research Hospital, Memphis, Tennessee

Key details

Sponsor

St. Jude Children's Research Hospital

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~352 participants

Started

December 2020

Primary completion

March 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

13 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.